Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,478 | 807 | 99.1% |
| Education | $101.52 | 11 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,505 | 175 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,655 | 102 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $833.20 | 63 | $0 (2022) |
| Merck Sharp & Dohme LLC | $762.12 | 51 | $0 (2022) |
| Novo Nordisk Inc | $742.54 | 60 | $0 (2024) |
| PFIZER INC. | $732.29 | 64 | $0 (2021) |
| Amgen Inc. | $722.48 | 61 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $532.80 | 35 | $0 (2020) |
| Lilly USA, LLC | $424.64 | 34 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $419.70 | 35 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.34 | 3 | Bayer Healthcare Pharmaceuticals Inc. ($126.26) |
| 2022 | $1,618 | 93 | Janssen Pharmaceuticals, Inc ($277.97) |
| 2021 | $1,747 | 114 | AstraZeneca Pharmaceuticals LP ($347.55) |
| 2020 | $1,707 | 110 | PFIZER INC. ($296.12) |
| 2019 | $2,056 | 152 | Janssen Pharmaceuticals, Inc ($493.19) |
| 2018 | $1,989 | 157 | Janssen Pharmaceuticals, Inc ($490.72) |
| 2017 | $2,166 | 189 | Janssen Pharmaceuticals, Inc ($615.17) |
All Payment Transactions
818 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $77.36 | General |
| Category: Obesity | ||||||
| 06/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $126.26 | General |
| Category: Cardio-renal | ||||||
| 04/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $93.72 | General |
| Category: Oncology | ||||||
| 12/12/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: PRIMARY CARE | ||||||
| 12/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: DIABETES | ||||||
| 12/05/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Cardio-renal | ||||||
| 11/28/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Cardio-renal | ||||||
| 11/16/2022 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/27/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Cardio-renal | ||||||
| 10/20/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: PRIMARY CARE | ||||||
| 10/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Inflammation | ||||||
| 09/22/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Cardio-renal | ||||||
| 09/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: PRIMARY CARE | ||||||
| 09/13/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 501 | 862 | $169,131 | $52,886 |
| 2021 | 10 | 822 | 1,160 | $199,291 | $83,165 |
| 2020 | 12 | 890 | 1,404 | $172,591 | $87,375 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 220 | 533 | $95,940 | $28,175 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 174 | $44,370 | $13,251 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 79 | 79 | $26,307 | $9,946 | 37.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 39 | $1,599 | $1,105 | 69.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 13 | 13 | $507.00 | $260.91 | 51.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 23 | 24 | $408.00 | $148.47 | 36.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 212 | 437 | $67,140 | $24,380 | 36.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 134 | 134 | $44,220 | $22,000 | 49.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 130 | 195 | $38,395 | $13,365 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 63 | 63 | $20,896 | $8,019 | 38.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 96 | 96 | $12,459 | $6,200 | 49.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 80 | $6,181 | $4,468 | 72.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 105 | 105 | $4,294 | $1,723 | 40.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 12 | $3,467 | $1,525 | 44.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 26 | 26 | $2,035 | $1,414 | 69.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 12 | 12 | $204.00 | $72.27 | 35.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 179 | 337 | $65,715 | $34,414 | 52.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 182 | 336 | $48,720 | $20,024 | 41.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 21 | 53 | $12,635 | $9,416 | 74.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 64 | 129 | $9,972 | $7,409 | 74.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 38 | 39 | $8,444 | $5,065 | 60.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 94 | 111 | $11,100 | $3,443 | 31.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 48 | 50 | $3,914 | $2,812 | 71.9% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 118 | 119 | $6,188 | $2,310 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 113 | 116 | $3,480 | $1,872 | 53.8% |
About Dr. Paul Kirsch, M.D
Dr. Paul Kirsch, M.D is a Internal Medicine healthcare provider based in Bradford, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598759128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Kirsch, M.D has received a total of $11,579 in payments from pharmaceutical and medical device companies, with $297.34 received in 2024. These payments were reported across 818 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($11,478).
As a Medicare-enrolled provider, Kirsch has provided services to 2,213 Medicare beneficiaries, totaling 3,426 services with total Medicare billing of $223,427. Data is available for 3 years (2020–2022), covering 28 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bradford, PA
- Active Since 09/09/2005
- Last Updated 03/17/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598759128
Products in Payments
- XARELTO (Drug) $1,905
- FARXIGA (Drug) $819.91
- INVOKANA (Drug) $593.81
- JANUVIA (Drug) $445.34
- ENTRESTO (Drug) $392.40
- JARDIANCE (Drug) $380.57
- NURTEC ODT (Drug) $324.54
- TOUJEO (Drug) $309.29
- STIOLTO RESPIMAT (Drug) $304.92
- Kerendia (Drug) $298.78
- UBRELVY (Drug) $273.26
- TRINTELLIX (Drug) $262.47
- COLOGUARD (Device) $261.96
- Tresiba (Drug) $244.40
- Prolia (Biological) $235.87
- CHANTIX (Drug) $211.44
- Ozempic (Drug) $207.08
- BEVESPI AEROSPHERE (Drug) $203.00
- TRELEGY ELLIPTA (Drug) $191.75
- LYRICA (Drug) $187.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bradford
Dr. Jakub Wojcik, Md, MD
Internal Medicine — Payments: $6,687
Fayez Roumani, M.d, M.D
Internal Medicine — Payments: $833.59
Dr. Kamran Saleh, M.d, M.D
Internal Medicine — Payments: $319.18
Peter Vaccaro
Internal Medicine — Payments: $123.19
Dr. John Severinghaus, M.d, M.D
Internal Medicine
Nadeen Hussain, Md, MD
Internal Medicine